Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Quattroflow™ to Feature Single-Use Biologic Pumps at INTERPHEX 2013

Published: Monday, January 28, 2013
Last Updated: Sunday, January 27, 2013
Bookmark and Share
Single-use pumps save time and money, and are quick and easy to change.

Quattroflow™ from Almatec® Maschinenbau GmbH, has announced that it will display the latest offerings in its single-use line of pumps for use in biologic-handling applications within pharmaceutical and biotech operations at INTERPHEX 2013 in Booth No. 2463.

The INTERPHEX show, which brings together a wide variety of leaders from the pharmaceutical industry, will be held from April 23-25, 2013, at the Jacob K. Javits Convention Center in New York, NY, USA.

The incorporation of single-use pumps in biologic-handling applications is gaining wider acceptance among pharmaceutical and biotech manufacturers because they can help optimize end-product speed-to-market.

Single-use, or disposable, pumps feature replaceable wetted pump chamber, which is an advantage for manufacturers looking to maximize their production operations.

Quattroflow positive displacement pumps are ideal for single-use systems because they incorporate a four piston-diaphragm technology with no mechanical seals that is driven by an eccentric shaft and motor.

Quattroflow pumps primarily serve the pharmaceutical and biotech industries in applications that require high containment, purity and cleanability, and are best known for transferring shear-sensitive media of aqueous solutions and biological products without damage, ultimately ensuring product safety, efficiency and reliability.

Quattroflow pumps feature wetted pump chambers made of plastic, while the valves are made of EPDM and the diaphragms of EPDM/PP compound.

The Quattroflow product line consists of four sizes - QF150, QF1200, QF4400, QF5050 and QF20K - with capacities of 1 to 20,000 lph (5283 gph).


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Flu Vaccine May Reduce Risk of Death For Type 2 Diabetes Patients
Researchers at Imperial College London have suggested that the vaccine may have substantial benefits for patients with long-term conditions.
Flu Vaccine May Reduce Death Risk of Type 2 Diabetes
New research suggests that a new flu vaccine may reduce probability of type 2 diabetes patients being hospitalised with stroke and heart failure.
Disrupting Tumour-Promotion in Humans
Researchers have modified an existing protein to represses a specific cancer-promoting ‘message’ within cells.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Vaccine Strategy Targets Multiple Influenza Viruses
Scientists have identified vaccine-induced antibodies that can neutralize strains of influenza virus that infect humans.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Structure of Cold Virus Solved
Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.
'Poison Pill' Fed to Deadly Virus
Researchers have created a genetic modification within a virus (with funny name), rendering it unable to replicate, mutate or cause illness.
World First Alzheimer's Vaccine Breakthrough
Researchers have made a breakthrough discovery towards an effective vaccine for Alzheimer's by targeting associated proteins.
Immunotherapy Drug Combo Targets Cancer
Mayo Clinic researchers identify potential immunotherapy drug combination that shows therapeutic effects against advanced and metastatic cancers.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!